MetaCap

Apnimed Inc. (APMD)

NASDAQ: APMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.04-0.61 (-3.27%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 18.04 0.00%

APMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$751.02M
52-week range
16.12 – 35.29
Day range
17.84 – 19.40
Volume / Avg
465.53K / 558.59K
Beta
—
Next earnings
Nov 11, 2026

52-week range

$16.12$35.29

APMD stock today

Apnimed (APMD) closed at $18.04 on Oct 7, down 3.27% (-$0.61), versus the S&P 500's 0.22% decline. At this level, APMD sits near the bottom of its 52-week range of $16.12 to $35.29: 48.9% below the high, set on Aug 18, 2026 and 11.9% above the low. Apnimed trades at 2.5x its trailing twelve-month earnings per share of $7.22.

Apnimed's next earnings report is expected on Nov 11, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Apnimed

Company profile
Industry
Biotechnology: Pharmaceutical Preparations
IPO year
2026

Earnings

Earnings history
Next report
Nov 11, 2026

Apnimed peers

Health Care sector
APMD peer companies
CompanyPrice% ChgMarket capCompare
GERNGeron Corporation1.20-0.83%$770.97Mvs APMD
LXRXLexicon Pharmaceuticals Inc.1.76+0.57%$783.12Mvs APMD
HELPHelus Pharma Inc.10.51-2.32%$767.86Mvs APMD
IMMXImmix Biopharma Inc.9.49-1.56%$786.75Mvs APMD
ANNXAnnexon Inc.4.01-0.50%$760.21Mvs APMD
IVAInventiva S.A. American Depository Shares3.37-2.75%$794.88Mvs APMD
VSTMVerastem Inc.8.27+6.65%$748.51Mvs APMD
GYREGyre Therapeutics Inc.7.04-0.56%$746.48Mvs APMD

Indexes, lists and sector

Apnimed stock FAQ

What is Apnimed's stock price today?

APMD last traded at $18.04 as of Oct 7, 4:00 PM EDT, down 3.27% on the day. Prices are delayed at least 15 minutes.

When is Apnimed's next earnings date?

Apnimed is expected to report earnings on Wednesday, November 11, 2026.

What is APMD's P/E ratio?

APMD trades at a trailing P/E ratio of 2.50.

What is the APMD 52-week high?

The 52-week high for APMD is $35.29 and the 52-week low is $16.12. The stock is currently 48.9% below its high.

Compare APMD